Skip to main content

Animations

MJFF Publications

6271 - 6280 of 9148 Results
Title
Year
  • Year
  • 2022
  • 2024
  • 2025
  • 2014
  • 2025
  • 2026
  • 2015
  • 2019
  • 2022
  • 2025
  • Summary Details
    OPEN
    Title: Palladium-Catalyzed α-Arylation of Cyclic β-Dicarbonyl Compounds for the Synthesis of CaV1.3 Inhibitors
    Journal Name: ACS Omega
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1021/acsomega.2c00889
    Citation Count: 7
  • Summary Details
    OPEN
    Title: P2RX7, an adaptive immune response gene, is associated with Parkinson's disease risk and age at onset
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x241296015
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Neural networks reveal novel gene signatures in Parkinson disease from single-nuclei transcriptomes
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01147-0
    Citation Count: 2
  • Design, synthesis, and evaluation of a selective chemosensor for leucine-rich repeat kinase 2
    2014
    Summary Details
    RESTRICTED
    Title: Design, synthesis, and evaluation of a selective chemosensor for leucine-rich repeat kinase 2
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2014.10.079
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Hemispheric lateralization of dopamine transporter binding in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108076
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Loss of serotonergic function in carriers of PRKN mutations: a [11C]DASB PET study
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00259-025-07693-2
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Improvement of dyskinesias withl-dopa infusion in advanced Parkinson's disease
    Journal Name: Acta Neurologica Scandinavica
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ane.12483
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Complementary motivational roles of nigroaccumbens and nigrostriatal dopaminergic pathways
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27504
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Cerebrospinal fluid and blood profiles of transfer RNA fragments show age, sex, and Parkinson's disease‐related changes
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/jnc.15723
    Citation Count: 31
  • Summary Details
    RESTRICTED
    Title: Frailty in prodromal Parkinson's disease in Medicare beneficiaries
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107965
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.